Effect of 0.05% topical cyclosporine for the treatment of symptomatic subepithelial infiltrates due to adenoviral keratoconjunctivitis

被引:0
|
作者
Muftuoglu, Ilkay Kilic [1 ]
Akova, Yonca A. [2 ]
Gungor, Sirel G. [3 ]
机构
[1] Istanbul Training & Res Hosp, Dept Ophthalmol, TR-34098 Istanbul, Turkey
[2] Bayindir Kavaklidere Hosp, Dept Ophthalmol, TR-06490 Ankara, Turkey
[3] Baskent Univ, Dept Ophthalmol, TR-06490 Ankara, Turkey
关键词
1-PERCENT CYCLOSPORINE;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:634 / 635
页数:2
相关论文
共 50 条
  • [31] Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine -: A controlled clinical pilot study
    Hillenkamp, J
    Reinhard, T
    Ross, RS
    Böhringer, D
    Cartsburg, O
    Roggendorf, M
    De Clercq, E
    Godehardt, E
    Sundmacher, R
    ARCHIVES OF OPHTHALMOLOGY, 2001, 119 (10) : 1487 - 1491
  • [32] Efficacy, Safety and Steroid-sparing Effect of Topical Cyclosporine A 0.05% for Vernal Keratoconjunctivitis in Indian Children
    Chatterjee, Arkendu
    Bandyopadhyay, Sabyasachi
    Bandyopadhyay, Samir Kumar
    JOURNAL OF OPHTHALMIC & VISION RESEARCH, 2019, 14 (04) : 412 - 418
  • [33] TOPICAL ADMINISTRATION OF CYCLOSPORINE FOR TREATMENT OF KERATOCONJUNCTIVITIS SICCA IN DOGS
    MORGAN, RV
    ABRAMS, KL
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1991, 199 (08) : 1043 - 1046
  • [34] Topical Use of Olopatadine and Cyclosporine a in Treatment of Vernal Keratoconjunctivitis
    Zaure, Knatova
    Aylin, Kantarci Feride
    Fikret, Akata
    Eugeniu, Vieru
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2016, 7 (04) : 488 - 493
  • [35] Symptomatic Treatment of Subepithelial Infiltrates after Viral Conjunctivitis: Loteprednol or Dexamethasone?
    Kocluk, Yusuf
    Sukgen, Emine Alyamac
    Cevher, Selim
    Mat, Emrah
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2017, 25 (05) : 654 - 658
  • [36] Corticosteroids Versus Cyclosporine for Subepithelial Infiltrates Secondary to Epidemic Keratoconjunctivitis: A Prospective Randomized Double-Blind Study
    Gouider, Dhouha
    Khallouli, Asma
    Maalej, Afef
    Yousfi, Mohamed Ali
    Ksiaa, Imen
    Bouguerra, Chaker
    Ajili, Faida
    Khairallah, Moncef
    CORNEA, 2021, 40 (06) : 726 - 732
  • [37] Topical cyclosporine a 0.5% as primary treatment for superiorlimbic keratoconjunctivitis.
    Perry, HD
    Donnenfeld, ED
    Kornstein, HS
    Storza, P
    Kanellopoulos, AJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S684 - S684
  • [38] Topical cyclosporine a inhibits subepithelial immune infiltrates but also promotes viral shedding in experimental adenovirus models
    Romanowski, EG
    Pless, P
    Yates, KA
    Gordon, YJ
    CORNEA, 2005, 24 (01) : 86 - 91
  • [39] Effect of Loteprednol Etabonate 0.5% on Initiation of Dry Eye Treatment With Topical Cyclosporine 0.05%
    Sheppard, John D.
    Donnenfeld, Eric D.
    Holland, Edward J.
    Slonim, Charles B.
    Solomon, Renee
    Solomon, Kerry D.
    McDonald, Marguerite B.
    Perry, Henry D.
    Lane, Stephen S.
    Pflugfelder, Stephen C.
    Samudre, Sandeep S.
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2014, 40 (05): : 289 - 296
  • [40] Pentacam corneal densitometry-guided treatment of adenoviral corneal subepithelial infiltrates: a comparative study between transepithelial phototherapeutic keratectomy and topical tacrolimus
    Elhamaky, Tarek Roshdy
    INTERNATIONAL OPHTHALMOLOGY, 2021, 41 (01) : 67 - 77